Company intelligence / Profile preview

GEK

Ownership: Private
Development stage: Other

Overview

GEK Lab offers commercialized diagnostic solutions that combine proprietary biomarker analysis, genetic screening, and clinical expertise to provide medical-grade reports and actionable health insights for chronic disease risk management[2].

Therapeutic areas: Other
Modalities: Biomarker analysis (proprietary methods)Genetic screening
Industry: Molecular Diagnostics

Partnerships

Collaborates with healthcare networks, pharmacies, and research centers in Italy and across the EU

Beyond the preview

Go deeper on GEK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GEK.

Explore the full profile